[EN] PIPERAZINE-2,5-DIONES AS TGF-BETA INHIBITORS<br/>[FR] PIPÉRAZINE-2,5-DIONES EN TANT QU'INHIBITEURS DE TGF-BÊTA
申请人:SOUTHERN RES INST
公开号:WO2020033317A1
公开(公告)日:2020-02-13
The present disclosure is concerned with piperazine-2,5-diones that are capable of inhibiting TGF-β and methods of treating cancers such as, for example, multiple myeloma and a hematologic malignancy, and methods of treating fibrotic conditions using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.